Bart Vansteenkiste

avatarAlt

Bart Vansteenkiste has worked for Domino for over 19 years in different commercial roles. As the Pharmaceutical key account manager for Belgium he then joined the headquarters based Life Sciences sector team in 2011 to focus on the EU FMD legislation. Since February 2016 Bart has been appointed Global life sciences sector manager and in this role, he is responsible for developing Domino’s Life Sciences business and strategy. Bart deals directly with Domino’s pharma key accounts head offices and keeps close contact with the sector trade associations. Bart also regularly attends and presents at conferences on behalf of Domino.

Articles from Bart Vansteenkiste

COVID-19: Key considerations when printing onto masks

Understanding how to add the necessary codes to masks is crucial for manufacturers – both for the efficiency of their business and the safety of their customers. There are health risks associated with incorrect coding practices. And different types of mask have different coding requirements. Let’s outline the key considerations.

BLOG

Other Pharma Emerging Legislation

The pharmaceutical sector is facing its greatest challenge to date; how to reduce the number of counterfeit and falsified medicines entering the legitimate supply chain.

BLOG

China CFDA eCode

The China Food and Drug Administration (CFDA) work to ensure the safety of food and healthcare products in the Chinese market. The drug regulation aims to protect patients from counterfeit pharmaceuticals and counterfeit traditional Chinese medicines.

BLOG